Follow The Filings

COYA position history

The shares of Coya Therapeutics (COYA) that DME Capital Management reported in each quarter’s 13F.

Equity, COMMON STOCK

Shares held by quarter

New Add Reduce Exit

  1. 2024 Q1: 1,274,026 shares, $13M, 0.58% of portfolio
  2. 2024 Q2: 1,274,026 shares, $7.7M, 0.38% of portfolio
  3. 2024 Q3: 1,274,026 shares, $8.2M, 0.34% of portfolio
  4. 2024 Q4: 1,646,440 shares, $9.4M, 0.49% of portfolio, Add +29.2%
  5. 2025 Q1: 1,646,440 shares, $11M, 0.54% of portfolio
  6. 2025 Q2: 1,646,440 shares, $9.5M, 0.41% of portfolio
  7. 2025 Q3: 1,646,440 shares, $9.4M, 0.37% of portfolio
  8. 2025 Q4: 2,025,940 shares, $12M, 0.41% of portfolio, Add +23.0%
  9. 2026 Q1: 2,335,540 shares, $9.2M, 0.29% of portfolio, Add +15.3%
  10. 2026 Q2: 2,335,540 shares, $14M, 0.35% of portfolio
  11. 2026 Q3: 2,335,540 shares, $12M, 0.33% of portfolio
Holdings date Value % of holdings Shares Filing date All 13F holders